Literature DB >> 35695600

Evaluation and Test Methods of Industrial Exoskeletons In Vitro, In Vivo, and In Silico: A Critical Review.

Liying Zheng1, Brian Lowe2, Ashley L Hawke1, John Z Wu1.   

Abstract

Industrial exoskeletons have been used to assist workers during occupational activities, such as overhead work, tool-use, mobility, stooping/squatting, and/or load carrying in various industries. Despite the promise of reducing the risk of work-related musculoskeletal disorders, there is a lack of sufficient evidence to support the safe and effective use of industrial exoskeletons. To assess the merits and residual risks of various types of exoskeletons in different work settings, more comprehensive evaluation procedures are needed. This review study aims to provide an overview of the existing viable and promising methods for evaluating the effectiveness of industrial exoskeletons. The different evaluation methods are organized into three categories-in vitro, in vivo, and in silico studies. The limitations and challenges in different types of evaluation approaches are also discussed. In summary, this review sheds light on choosing appropriate evaluation approaches and may help with decision-making during the development, evaluation, and application of industrial exoskeletons.

Entities:  

Mesh:

Year:  2021        PMID: 35695600      PMCID: PMC9199587          DOI: 10.1615/CritRevBiomedEng.2022041509

Source DB:  PubMed          Journal:  Crit Rev Biomed Eng        ISSN: 0278-940X


  38 in total

1.  Prefrontal cortex oxygenation and neuromuscular responses to exhaustive exercise.

Authors:  Thomas Rupp; Rupp Thomas; Stéphane Perrey; Perrey Stephane
Journal:  Eur J Appl Physiol       Date:  2007-09-20       Impact factor: 3.078

2.  The effects of exercise fatigue on prefrontal and motor activations as measured by near-infrared spectroscopy.

Authors:  Jun Wu; Tao Liu; Jianpeng Huang; Wenmin Han
Journal:  Neuroreport       Date:  2017-12-06       Impact factor: 1.837

3.  Shoulder muscle fatigue during repetitive tasks as measured by electromyography and near-infrared spectroscopy.

Authors:  Sue A Ferguson; W Gary Allread; Peter Le; Joseph Rose; William S Marras
Journal:  Hum Factors       Date:  2013-12       Impact factor: 2.888

4.  Neural and biomechanical tradeoffs associated with human-exoskeleton interactions.

Authors:  Yibo Zhu; Eric B Weston; Ranjana K Mehta; William S Marras
Journal:  Appl Ergon       Date:  2021-06-11       Impact factor: 3.661

5.  Assessing the influence of a passive, upper extremity exoskeletal vest for tasks requiring arm elevation: Part I - "Expected" effects on discomfort, shoulder muscle activity, and work task performance.

Authors:  Sunwook Kim; Maury A Nussbaum; Mohammad Iman Mokhlespour Esfahani; Mohammad Mehdi Alemi; Saad Alabdulkarim; Ehsan Rashedi
Journal:  Appl Ergon       Date:  2018-03-07       Impact factor: 3.661

6.  Physiological consequences of using an upper limb exoskeleton during manual handling tasks.

Authors:  Jean Theurel; Kevin Desbrosses; Terence Roux; Adriana Savescu
Journal:  Appl Ergon       Date:  2017-10-16       Impact factor: 3.661

7.  Biomechanical evaluation of exoskeleton use on loading of the lumbar spine.

Authors:  Eric B Weston; Mina Alizadeh; Gregory G Knapik; Xueke Wang; William S Marras
Journal:  Appl Ergon       Date:  2017-11-13       Impact factor: 3.661

8.  ASTM F48 Formation and Standards for Industrial Exoskeletons and Exosuits.

Authors:  Brian D Lowe; William G Billotte; Donald R Peterson
Journal:  IISE Trans Occup Ergon Hum Factors       Date:  2019

9.  Brain and central haemodynamics and oxygenation during maximal exercise in humans.

Authors:  José González-Alonso; Mads K Dalsgaard; Takuya Osada; Stefanos Volianitis; Ellen A Dawson; Chie C Yoshiga; Niels H Secher
Journal:  J Physiol       Date:  2004-03-05       Impact factor: 5.182

10.  EMG-driven forward-dynamic estimation of muscle force and joint moment about multiple degrees of freedom in the human lower extremity.

Authors:  Massimo Sartori; Monica Reggiani; Dario Farina; David G Lloyd
Journal:  PLoS One       Date:  2012-12-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.